Total Health

Event

2021 Virtual ESMO Review

presented by Total Health

1 other would like to attend.

Register Now

Notification icon Saturday, October 23, 2021 7:15 AM - Sunday, October 24, 2021 2:20 PM America/New_York

Event info

*Free Registration

The 2021 Virtual ESMO Review will be a condensed review of the global meeting held earlier in September and will give healthcare providers the opportunity to learn about the latest advances in oncology education and translate science into better patient care. This meeting will facilitate the exchange and debate of translational cancer science in a virtual format.

EDUCATIONAL OBJECTIVES

  • Examine scientific advances that further enhance knowledge of cancer biology and pathogenesis

  • Review recent and emerging data from key studies in clinical cancer research

  • Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of people with cancer

  • Implement clinical and scientific strategies designed to improve the quality of cancer care, as appropriate

  • Effectively communicate with colleagues and with patients regarding advances in clinical oncology science

  • Identify and utilize tools for cancer risk assessment and risk reduction based on the best available evidence

ACCREDITATION

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferencing. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Amedco LLC designates this live activity for a maximum of 9.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.

1 other would like to attend.

Register Now


0 Comments
Login to view comments. Click here to Login